Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
3
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
3
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alex azar
biotech
department of health and human services
drug prices
medicare
regeneron pharmaceuticals
scott gottlieb
alirocumab
alliance for aging research
american patients first
amgen
biogen
biosimilars
What
trump
3
×
administration
awaited
drug
drugs
house
long
plan
unveiled
white
afternoon
angry
anti
anticipated
benefited
blueprint
canada
canadian
cheaper
cost
costly
countries
cut
department
despite
details
excludes
fear
floats
health
import
industry
losing
lower
meant
medications
pharma
plans
pledges
prescription
Language
unknown
Current search:
trump
×
fda
×
" raleigh-durham top stories "
×
@xconomy.com
4 years ago
White House Floats Canadian Import Plan But Excludes Many Costly Drugs
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details